The Middle East Arthritis Foundation (MEAF), a non-profit organization that strives to breathe life into leading ideas on health, hope and happiness, will host its first in-person event in two years on 15th October 2022, at the Shangri La Hotel, Dubai, to mark World Arthritis Day (WAD), observed globally on 12th October every year to spread awareness on arthritis and ease the struggles of people fighting this debilitating disease. This year’s event under the theme ‘Inspired by Patients…Driven by Passion!’ aims to underline the importance of awareness about the symptoms of various autoimmune and rheumatic musculoskeletal conditions, as early diagnosis of auto-immune diseases such as arthritis can lead to better treatment possibilities and interventions.

UPS Healthcare and The UPS Foundation are collaborating with PROMEDEO, an innovative medical supply chain company, and Ideabatic, an award-winning humanitarian organization, to solve critical last-mile cold chain issues in Cameroon.

Over the past 100 years, significant advancements have been made in spinal fusion to treat scoliosis. These advancements have led to improved fusion rates, lower complication frequency, greater three-dimensional correction of the deformity and more rapid postoperative recovery.

Today the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) announced it awarded more than $3.6 million in competitive grants to seven organizations working to bolster support for individuals experiencing substance use disorder (SUD) during pregnancy and postpartum. Five of the recipients also will use the funds to address the intersection of SUD and intimate partner violence (IPV). This work builds on the HHS overdose prevention strategy and will advance the President’s unity agenda and the White House Blueprint for Addressing the Maternal Health Crisis released earlier this year to improve maternal health and advance health equity.

Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the investigational combination of trifluridine/tipiracil plus bevacizumab showed a statistically significant improvement in the primary endpoint of overall survival (OS) compared to trifluridine/tipiracil alone in a Phase III clinical trial of participants with refractory metastatic colorectal cancer (mCRC) following two chemotherapy regimens.

Geneva-based Hôpital de La Tour is providing patients from GCC with a range of services to help them control and reduce their weight and improve their overall health in an effort to combat obesity. Hôpital de La Tour, the leading private hospital in Geneva, provides multidisciplinary specialized services with a wide range of offerings and takes advantage of various on-site specialists dedicated to treating all aspects of obesity.

enterslots kdslots777 vegasgg autospin88 pilot138 jempol88 playbet88 luxury333 fit188 bigdewa megahoki88 warung168 rajacuan gas138 nusa365 gebyar123 harmonibet kencana88 bimabet max77 dragon77 infini88 vegasgg rajacuan ajaib88 vegasslot77 garuda999 vegashoki88 koinvegas mantul138 7winbet